Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapy with ligands of natural killer T cells.

Trends in molecular medicine - 1 May 2002

Wilson Michael T, Singh Avneesh K, Van Kaer Luc

Abstract excerpt

Natural killer T (NKT) cells are innate lymphocytes that share receptor structures and functions with conventional T cells and natural killer cells. NKT cells are specific for glycolipid antigens bound by the major histocompatibility complex class I-like protein CD1d. One striking property of NKT cells is their capacity to rapidly produce large amounts of cytokines in response to T-cell receptor engagement,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD1
Share to Antigens, CD1d
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycolipids

Share to Immunotherapy

Share to Killer Cells, Natural

Share to Ligands

Share to Models, Chemical

Source

Identifiers

PMID: 12067632
DOI: 10.1016/s1471-4914(02)02325-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy with ligands of natural killer T cells.PMID 12067632Read ↗

Advantages and clinical applications of natural killer cells in cancer immunotherapy.Semantic proximity Read ↗

The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional ApproachSemantic proximity Read ↗

Cytotoxic CD8+ T cells in cancer and cancer immunotherapySemantic proximity Read ↗

Natural Killer Cells: From Innate to Adaptive FeaturesSemantic proximity Read ↗

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.Semantic proximity Read ↗

Adjuvant and immunomodulatory potential of <i>in vivo</i> Natural Killer T (NKT) activation by NKTT320Semantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

NKT cells - New players in CAR cell immunotherapy?Semantic proximity Read ↗

IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.Semantic proximity Read ↗

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futureSemantic proximity Read ↗

NKG2D Ligands in Tumor Immunity: Two Sides of a CoinSemantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.